AEON icon

AEON Biopharma
AEON

Overview Fund Activity

15 hedge funds and large institutions have $29.3M invested in AEON Biopharma in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.24%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
14
Increased
1
Reduced
–
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACM
Atalaya Capital Management
New York
+$19.8M
2
RCM
Rivernorth Capital Management
Florida
+$3.4M
3
IC
Ikarian Capital
Texas
+$1.44M
4
BlackRock
BlackRock
New York
+$1.35M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.08M

Top Sellers

1
SCM
Saba Capital Management
New York
-$2.49M
2
FTCM
Fir Tree Capital Management
New York
-$2M
3
PC
Periscope Capital
Ontario, Canada
-$1.58M
4
ECP
Empyrean Capital Partners
California
-$1.42M
5
TCM
Tenor Capital Management
New York
-$1.42M
Name Holding Trade Value Shares
Change 		Shares
Change %
Walleye Capital
26
Walleye Capital
New York
– -$129K -253 Closed
CS
27
Clear Street
New York
– -$127K -250 Closed
MC
28
Meteora Capital
Florida
– -$106K -208 Closed
Walleye Trading
29
Walleye Trading
New York
– -$72.6K -143 Closed
CAC
30
Cowen and Company
New York
– -$70.8K -139 Closed
AA
31
Ancora Advisors
Ohio
– -$41.1K -81 Closed
Barclays
32
Barclays
United Kingdom
– -$1K -3 Closed
1
2